A study demonstrates effects of glucagon-like peptide-1 receptor agonists on pregnancy outcomes, suggesting important considerations.
To the Editor A recent study that used a propensity score and 1:3 matching provided valuable insight into the potential effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) during pregnancy.1 Nevertheless, several limitations warrant careful consideration.
No takes yet. Share an insight, caveat, or question.
J. Boujenah (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: